This tumour‐promoting metabolic switch mediates by transforming growth factor signalling, activating HIF‐1α‐transcription, oncogene activation or tumour suppressor gene loss and maintaining tumour cell survival and development in the harsh tumour microenvironment.67 The gene discussed is HIF1A; the disease is neoplasm.